期刊文献+

小剂量氢氯噻嗪联合依那普利治疗高血压疗效观察 被引量:3

Observation on the curative effect of low dose hydrochlorothiazide combined with enalapril in essential hypertension
下载PDF
导出
摘要 目的:探讨小剂量氢氯噻嗪与依那普利单用及联合应用治疗高血压患者的临床疗效。方法:96例高血压患者随机分为小剂量氢氯噻嗪组、依那普利组、氢氯噻嗪联合依那普利组,每组32例,疗程4周,比较3组治疗前后降压疗效及达标率。结果:3组血压下降显著(P<0.05),氢氯噻嗪组与依那普利组血压下降比较差异无显著性(P>0.05),联合用药组较单独用药组血压下降更显著(P<0.05)。联合用药组降压有效率75%,达标率71.89%,分别与单独用药组比较P<0.05。结论:小剂量氢氯噻嗪和依那普利单用或联用治疗原发性高血压有效,但两药联用显著提高降压疗效及达标率,联用不良反应减少。 Objective :To investigate the clinical effect of low dose hydrochlorothiazide and enalapril alone or combination of both in the treatment of essential hypertension.Methods:96 patients with essential hypertension were randomly divided into low dose hydrochlorothiazide group,enalapril group and hydrochlorothiazide and enalapril group,with 32 cases in each group.and treated with the appropriate drugs for 4 weeks.The condition of decreased blood pressure before and after treatment,antihypertensive effect and standardreaching rate were compared among the three groups.Results:After treatment,blood pressure decreased significantly among the three groups (P〈0.05),there was no obvious difference in decreasing the blood pressure between the hydrochlorothiazide group and enalapril group (P〉05),but the antihypertensive effect in the drug combination of both was more significant compared with that in two drugs used alone(P〈0.05).The effective rate of depressurization in the hydrochorothiazide and enalapril group was 75% and its standard-reaching rate was 71.89%,and had significant difference from those in the single administration group (P〈0.05).Conclusion:Low dose hydrochloroth- iazide and enalapril alone or combination of both in essential hypertension is effective,the drug combination of both can significantly improve the antihypertensive effect and standard-reaching rate, with less adverse reaction.
机构地区 金堂县中医院
出处 《现代医药卫生》 2008年第17期2551-2552,共2页 Journal of Modern Medicine & Health
关键词 小剂量氢氯噻嗪 依那普利 高血压 疗效 Low dose hydrochlorothiazide Enalapril Essential hypertension Curative effect
  • 相关文献

参考文献7

二级参考文献27

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 2Pepine C J,Handberg EM,Cooper-DeHoff RM,et al.A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease.The International Verapamil-Trandolapril Study (INVEST):a randomized controlled trial.JAMA,2003,290:2805-2816. 被引量:1
  • 3Weber MA,Julius S,Kjeldsen SE,et al.Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.Lancet,2004,363:2049-2051. 被引量:1
  • 4Mourad JJ,Waeber B,Zannad F,et al.Comparison of different therapeutic strategies in hypertension:a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach.J Hypertens,2004,22:2379-2386. 被引量:1
  • 5Dahlof B,Sever PS,Poulter NR,et al.Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required,in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):a multicentre randomised controlled trial.Lancet,2005,366:895-906. 被引量:1
  • 6Pickkers P,Garcha RS,Schachter M,et al.Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide.Hypertension,1999,33:1043-1048. 被引量:1
  • 7Sturkenboom M,Picelli G,Dieleman JP,et al.Patient adherence and persistence with antihypertensive therapy:one-versus two-pill combination.Presented at the 15th European Meeting on Hypertension,Milan,Italy,June 17-21,2005. 被引量:1
  • 8Luis M,Emesto L.Blood pressure control and benefits of antihypertensive therapy-doesit make a difference which agents we use? Hypertension,2002,38(Part 2):537-542. 被引量:1
  • 9Shah SU,Anjum S,Littler WA.Use of diuretics in cardiovascular disease:(2) hypertension.Postgrad Med J,2004,80:271-276. 被引量:1
  • 10Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.Diuretic versus alphablocker as first-step antihypertensive therapy:final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).Hypertension,2003,42:239-246. 被引量:1

共引文献2701

同被引文献24

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部